Building a leading microbiome

company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

March 13, 2023

February 23, 2023: Les Echos Investir – Maat Pharma : l’approche novatrice du microbiote (French only)

March 8, 2023

February 22, 2023: Microbiome Post – Interview of Hervé Affagard

March 2, 2023

March 2, 2023: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital

Like what you see? See more posts

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!